Nu Skin Enterprises, Inc. (NYSE:NUS) Chairman Steven Lund Sells 17,129 Shares of Stock

Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) Chairman Steven Lund sold 17,129 shares of the stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $45.18, for a total value of $773,888.22. Following the transaction, the chairman now owns 20,800 shares in the company, valued at approximately $939,744. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Steven Lund also recently made the following trade(s):

  • On Tuesday, June 21st, Steven Lund sold 6,426 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.02, for a total value of $289,298.52.
  • On Friday, June 17th, Steven Lund sold 900 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.01, for a total value of $40,509.00.
  • On Wednesday, June 15th, Steven Lund sold 395 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.00, for a total value of $17,775.00.
  • On Monday, June 13th, Steven Lund sold 51,300 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $43.83, for a total value of $2,248,479.00.
  • On Wednesday, May 18th, Steven Lund sold 925 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $46.07, for a total value of $42,614.75.
  • On Monday, May 16th, Steven Lund sold 21,200 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.25, for a total value of $959,300.00.

NYSE:NUS traded up $0.84 during trading hours on Thursday, hitting $45.55. The company’s stock had a trading volume of 311,809 shares, compared to its average volume of 665,974. The stock has a fifty day simple moving average of $45.47 and a 200-day simple moving average of $48.05. The company has a market capitalization of $2.29 billion, a P/E ratio of 16.56 and a beta of 1.23. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.72 and a quick ratio of 0.95. Nu Skin Enterprises, Inc. has a twelve month low of $39.40 and a twelve month high of $58.97.

Nu Skin Enterprises (NYSE:NUSGet Rating) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.03. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. The business had revenue of $604.90 million for the quarter, compared to analyst estimates of $579.70 million. During the same period last year, the firm posted $0.91 earnings per share. Nu Skin Enterprises’s revenue was down 10.7% compared to the same quarter last year. On average, equities analysts predict that Nu Skin Enterprises, Inc. will post 3.8 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th were paid a dividend of $0.385 per share. This represents a $1.54 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date was Thursday, May 26th. Nu Skin Enterprises’s payout ratio is 57.04%.

Hedge funds have recently made changes to their positions in the company. TCI Wealth Advisors Inc. boosted its stake in shares of Nu Skin Enterprises by 66.6% during the fourth quarter. TCI Wealth Advisors Inc. now owns 758 shares of the company’s stock valued at $38,000 after purchasing an additional 303 shares in the last quarter. Covestor Ltd bought a new position in shares of Nu Skin Enterprises during the fourth quarter worth about $48,000. Quadrant Capital Group LLC raised its position in shares of Nu Skin Enterprises by 47.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock worth $54,000 after acquiring an additional 342 shares during the last quarter. JJJ Advisors Inc. raised its position in shares of Nu Skin Enterprises by 216.9% during the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company’s stock worth $95,000 after acquiring an additional 1,280 shares during the last quarter. Finally, Gladius Capital Management LP bought a new position in shares of Nu Skin Enterprises during the fourth quarter worth about $98,000. 93.79% of the stock is currently owned by hedge funds and other institutional investors.

A number of brokerages recently commented on NUS. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research report on Tuesday, June 7th. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Wednesday. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of “Moderate Buy” and an average price target of $61.50.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

See Also

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.